type here...

CATEGORIES

Pharmaceutics

LATEST

1234...11Page 3 of 11

TRENDING

EDITORS CHOICE

The Diversion of Drugs Within Healthcare Needs to be Addressed

Medika Life -
The Protenus Drug Diversion Digest found that over half of diversion incidents took place in a hospital, medical center, or physician practice setting

FDA approves Ready-to-Use Ephedrine Injection, Emerphed™

Medika Life -
Nexus Pharmaceuticals, Inc. Announces Approval of Emerphed™ (ephedrine sulfate) Injection, the First and Only FDA-approved, Ready-to-Use Ephedrine Injection (50 mg/10 mL vial)

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

This Vaccine Has Been Wildly Successful

Michael Hunter, MD -
VACCINES HAVE SLASHED RATES OF HUMAN PAPILLOMAVIRUS. Physicians began recommending the first vaccine for the remarkably common sexually transmitted HPV virus in 2006 in the United States.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories